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Fibromyalgia syndrome (FMS) is a complex disorder where widespread musculoskeletal
pain is associated with many heterogenous symptoms ranging from affective
disturbances to cognitive dysfunction and central fatigue. FMS is currently
underdiagnosed and often very poorly responsive to pharmacological treatment.
Pathophysiology of the disease remains still obscure even if in the last years fine
structural and functional cerebral abnormalities have been identified, principally by
neurophysiological and imaging studies delineating disfunctions in pain perception,
processing and control systems. On such basis, recently, neurostimulation of brain
areas involved in mechanism of pain processing and control (primary motor cortex:
M1 and dorsolateral prefrontal cortex: DLPFC) has been explored by means of
different approaches and particularly through non-invasive brain stimulation techniques
(transcranial magnetic and electric stimulation: TMS and tES). Here we summarize
studies on tES application in FMS. The great majority of reports, based on direct currents
(transcranial direct currents stimulation: tDCS) and targeting M1, showed efficacy on
pain measures and less on cognitive and affective symptoms, even if several aspects
as maintenance of therapeutical effects and optimal stimulation parameters remain
to be established. Differently, stimulation of DLPFC, explored in a few studies, was
ineffective on pain and showed limited effects on cognitive and affective symptoms.
Very recently new tES techniques as high-density tDCS (HD-tDCS), transcranial random
noise stimulation (tRNS) and tDCS devices for home-based treatment have been
explored in FMS with interesting even if very preliminary results opening interesting
perspectives for more effective, well tolerated, cheap and easy therapeutic approaches.
Keywords: non-invasive brain stimulation (NIBS), transcranial electrical stimulation (tES), fibromyalgia (FM),
tDCS — transcranial direct current stimulation, tRNS (transcranial random noise stimulation)
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INTRODUCTION
Fibromyalgia syndrome (FMS) is a complex disorder where a
widespread musculoskeletal pain (without a clear lesion basis) is
associated with a great variety of symptoms including affective
disturbances, central fatigue, cognitive dysfunction and even a
particular skin reactivity to several chemical substances (Cassisi
et al., 2008; Bazzichi et al., 2016). The manifestations of the
disease are responsible for a consistent clinical burden that
severely affects life quality of FMS patients. Indeed, aside
pain, patients are disabled by sleep disturbances, anxiety and
depression and by a complex cognitive dysfunctioning picture
characterized by disturbance in attention, working memory and
executive functions globally known as “fibrofog” often referred by
the patients as a sense of confusion, slowing down and clumsiness
that can severely impact the ability to effectively plan and perform
daily activities (Tesio et al., 2015; Gelonch et al., 2016).
Despite intense research effort, especially in the last years,
the pathophysiology of the disease remains to be clarified.
However, principally thanks to electrophysiological and
brain imaging techniques, some important advance has been
obtained concerning the putative brain structural and functional
abnormalities underlying the clinical manifestation of FMS.
On such basis, great attention was pointed toward the role
of central dysfunctional mechanisms in pathophysiology
of FMS and the targets for research and potential new
treatments moved to brain areas and networks involved in
pain processing and control (prefrontal, insular and posterior
cingulate regions) that can be accessed directly or through
connected areas like motor cortex or dorsolateral prefrontal
cortex. In this regard, particular interest has been raised by
techniques able to perform effective modulation of brain areas
through magnetic or electric currents applied to the scalp like
transcranial magnetic and electrical stimulation (TMS and
tES) (Hou et al., 2016; Zhu et al., 2017). TMS and tES are
safe, non-invasive brain stimulation (NIBS) approaches that
are able to modulate the activity of cortical areas inducing
lasting effects that have been employed to investigate and treat
neuropsychiatric diseases and pain disorders. Among NIBS
techniques, tES seems particularly attractive as it is based on
easy to use, quite cheap and small devices that appear suitable
for patient’s self-use and home-based treatments (Lefaucheur
et al., 2017). The potential therapeutic role of tES appears
also relevant considering that most pharmacological and
non-pharmacological treatments available are generally poorly
effective or show only transitory efficacy.
Principal aim of the present paper was to perform a structured
review concerning evidence on tES treatment for fibromyalgia
with particular regard to transcranial directs stimulation (tDCS)
that represents the most studied approach. We present also
an overview on new tES techniques drawing perspective for
future development. We discuss the results obtained in terms
of effectiveness and safety, mentioning also the controversial
aspect and raising suggestions for evaluating the real efficacy
of the technique and for further therapeutic developments. The
analysis of tES studies will be preceded by introductory notes on
tES techniques and on pathophysiology of FMS with particular
reference to area or network dysfunctions that could represent
useful targets for neurostimulation.
tES: PRINCIPLES AND TECHNIQUES
Transcranial electrical stimulation is a neurophysiological
technique able to perform effective, safe, not invasive and painless
brain stimulation in humans (Paulus, 2011). tES works through
low amperage electric fields delivered through surface electrodes
applied on the scalp. The first and the most common tES
approach used works through direct currents: transcranial direct
currents stimulation (tDCS) (Figure 1). Differently from TMS,
tDCS is not able to trigger direct neuronal activation but rather
exerts its effect through the polarization of the underlying neural
cell membranes. Anodal currents induce neuronal depolarization
increasing excitability and spontaneous neural firing while the
reverse occurs with cathodal stimulation. tDCS can induce
plastic effects that last after stimulation. In the seminal study
by Nitsche and Paulus (2000), tDCS of motor cortex induced
effects on motor evoked potential (facilitation by anodal and
inhibition by cathodal currents) that remained for 5–10 min
after stimulation. On such a basis, tDCS has been then applied
over repeated stimulation sessions, in a manner similar to rTMS
treatment protocols, with the aim to induce more lasting and
effective modulation and showed promising results, in terms
of efficacy and safety, for treatment of different chronic pain
states and of many other neurological and psychiatric disorders
(Nitsche et al., 2008; Lefaucheur et al., 2017). Recently, new
tES approaches have been developed, potentially more effective
and alternative to tDCS, to investigate and treat brain diseases.
Among these, mention deserves high-definition tDCS (HD-
tDCS), that increases the focality of stimulating currents, and
transcranial alternating current stimulation (tACS), a technique
using alternate currents delivered at different frequencies, with
the aim to interact with the ongoing cortical neurons oscillations.
HD-tDCS uses a particular electrodes’ arrangement with one
target electrode (anode or cathode) much smaller than those used
for tDCS, surrounded by a group of four equidistant electrodes
with opposite polarity. This to get a more focal current flow
of the required polarity over the target area, to have more
focused, less diffuse and hypothetically more effective facilitatory
or inhibitory effects. Therapeutic evidence of HD tDCS is till
now poor and limited, in pain states, to fibromyalgia. Other
even more preliminary applications concern tinnitus, aphasia,
(Richardson et al., 2015; Lefaucheur et al., 2017) memory loss
in MCI syndrome (Hampstead et al., 2017), epilepsy (Karvigh
et al., 2017) and auditory hallucination in schizophrenic patients
(Sreeraj et al., 2018).
Transcranial alternating current stimulation work through
alternate, sinusoid currents that change polarity between
electrodes at different stimulation frequencies. Currents can also
be delivered at not fixed oscillating rate but with randomly
changing frequencies across stimulation: transcranial random
noise stimulation (tRNS) (Paulus, 2011; Fertonani and Miniussi,
2017) (Figure 1). Differently from tDCS, tACS induce none
polarization effect and it should exert a modulatory interaction
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FIGURE 1 | Different forms of transcranial electrical stimulation. mA (milliampere). Stimulating current can be: direct, continuous (transcranial direct current
stimulation: tDCS) (1) that can be anodal or cathodal; alternate (2) with polarity changing a different frequency between anode and cathode at fixed (2A transcranial
alternate current stimulation: tACS) or randomly changing frequency (2B transcranial random noise stimulation: tRNS). Different montages (3) can also be applied
(anodal stimulation of M1 is exemplified in the picture). In classical tDCS (3A) anode is on the target and cathode in the reference area (contralateral supraorbital
region); in the case of High definition-tDCS (HD-tDCS) (3B) anode (more smaller in size to increase focality) is positioned over the target area and is surrounded by
four equally-spaced cathodes.
with the ongoing brain activity at a specific stimulation
frequency. Such interaction, defined as entrainment, has been
demonstrated in experimental animals (Reato et al., 2013) but
also studies in humans showed effects on sensory and motor
cortex suggesting entrainment (Hermann et al., 2013; Guerra
et al., 2016). However, no study has so far explored potential
effects of tACS for treatment of pain and other neuropsychiatric
diseases. Differently from tACS that oscillate at fixed frequency,
tRNS can induce a more generalized activation, thanks to the
wide range of stimulation frequencies employed, based on the
principle of stochastic resonance. According to this, a signal
that is too weak to reach a certain threshold can be increased
by adding noise (Fertonani and Miniussi, 2017) (Figure 2). In
this way tRNS can favor the synchronization of nervous stimuli,
through the amplification of neural sub-threshold activity. Motor
cortex tRNS induced an effect stronger than anodal tDCS
on cortical excitability in healthy subjects (Moliadze et al.,
2014; Inukai et al., 2016), improved neuropathic pain in some
case series (Alm and Dreimanis, 2013) and ameliorated pain
and cognitive dysfunction in patients with multiple sclerosis
(Palm et al., 2016).
PATHOPHYSIOLOGY OF FIBROMYALGIA
AND POTENTIAL TARGETS FOR
NEUROSTIMULATION
Pathophysiological mechanisms underlying the multifaceted
clinical picture of fibromyalgia remain largely obscure. Recently,
however, the application of new investigational approach able to
better explore structural and functional brain changes has been
successfully applied to the study of FMS revealing abnormalities
that could at least in part account for the complex pain perception
and processing dysfunction underlying the manifestations of
the disease.
Fibromyalgia is considered a chronic pain syndrome
characterized by an increased responsivity to painful stimuli.
FMS patient have normal ability to perceive sensory stimuli but
show reduced thresholds to pain (Lautenbacher and Rollman,
1997; Dadabhoy and Clauw, 2006). Such dysfunctions have
been suggested to depend upon both central sensitization
mechanisms and defective activity of the Diffuse Noxious
Inhibitory Controls (DNIC) pathways that are involved in the
inhibitory modulation of nociceptive input (Lee et al., 2011;
Ceko et al., 2012).
According to this, electrophysiology and functional magnetic
resonance imaging, revealed an abnormally increased reactivity
of cortical regions of the pain network involved, at different
extent, in pain perception and processing like medial prefrontal
and insular areas, sensory and motor cortex and cerebellum,
while a decreased activity and connectivity was found in areas
and network exerting inhibitory control on nociceptive input
like rostral anterior cingulate regions (Gracely et al., 2002; Diers
et al., 2008; de Tommaso, 2008; Jensen et al., 2013; Plazier et al.,
2015; Truini et al., 2015; Lopez-Sola et al., 2017; Sawaddiruk
et al., 2017). In line with these observations, FMS patients showed
also abnormalities of functional connectivity in Default mode
network (DMN) mainly affecting the referential DMN and the
executive control network (Pujol et al., 2014). These changes are
similar to those reported in other chronic pain states and are
considered to depend on effects of persisting pain on brain (Baliki
et al., 2008). Changes in prefrontal. cingulate and insular areas
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FIGURE 2 | The stochastic Resonance, a phenomenon invoked to explain the effects of tACS and more in particular of tRNS. According to this principle a signal
containing a high level of noise has more chance to increase excitability of neurons that are near to activation threshold making them to discharge.
excitability and connectivity were found also to play a role in
other relevant manifestation of FMS like affective disturbance
and fatigue.
Functional differences in cortical excitability emerged also in
a study using TMS of motor cortex in FMS patients. The report
showed increased motor threshold, thus a lower corticospinal
excitability and reduced short lasting intracortical inhibition
(SICI) as well as reduced intracortical facilitation (ICF), that
could be related to reduced intracortical GABA and glutamate
modulating circuits (Mhalla et al., 2010). Moreover, in a seminal
study, Antal et al. (2010) showed that anodal tDCS, can induce a
parallel reduction of both SICI and pain perception at VAS scale
in FMS patients. Interestingly, other pain states showed a similar
condition of reduced SICI and facilitatory stimulation of M1
was able to exert an analgesic effect, restoring also intracortical
inhibition (Lefaucheur, 2016).
In agreement with functional changes, also fine structural
abnormalities of the gray matter of the same dysfunctional
regions emerged from studies using the Voxel Based
Morphometry (VBM) technique, that can explore with great
detail neuronal density of cortical areas. VBM indeed showed
changes in gray matter of prefrontal, insular and cingulate cortex
in FMS patients that correlated with intensity of pain, cognitive
and affective impairment (Jorge and Amaro, 2012; Jensen et al.,
2013; Cagnie et al., 2014; Lin et al., 2016). Taken together these
finding seem to delineate a critical network of areas within the
pain network that can account for the clinical spectrum of FMS.
Indeed, according to a relevant hypothesis, pain and other FMS
symptoms can co-occur sharing underlying neural networks
(Luerding et al., 2008). Moreover, based on known connectivity
of neural structures involved in pain processing and control and
on evidence on other pain states, two areas: M1 and DLPFC
emerge as optimal candidates for therapeutic neuromodulation.
M1 stimulation was found indeed effective for treatment of
chronic pain, likely through an inhibitory effect on sensory
component of pain while DLPFC, through its connection with
limbic system and the DNIC system can exert a modulatory
effect on both pain and cognitive and affective symptoms of FMS
(Lefaucheur, 2016).
METHODS
Data Sources and Selection Criteria
We searched three data bases: PubMed, Cochrane library and
Scopus until August 1, 2018 for articles published in English
with the search terms: “fibromyalgia” and “transcranial” in
the field “Title or Abstract.” As concerns tDCS we included
only randomized controlled trials, where the diagnosis of
Fibromyalgia was made according to the criteria of American
College of Rheumatology (1990 or 2010 ACR: Wolfe et al., 1990,
2010). We excluded non-randomized (controlled or open label)
papers, single case reports and reviews, papers with patients not
meeting ACR criteria for FMS.
Differently, studies based on new tES approaches, other than
tDCS, were all mentioned and described even if only those with
randomized controlled design were included in the analysis.
Authors BF and BG performed independently the search and
selection of the papers and possible disagreement was solved
through consultation with a third author (CG).
Analysis of Risk Bias
Risk bias in the selected studies was explored trough the
specifically suited Cochrane tool (Higgins et al., 2011) designed
to examine different potential sources of bias: selection bias
(random generation sequence and allocation concealment),
blinding (subject and assessor), incomplete outcome data
(attrition bias), selective reporting (reporting bias), carry over
effects (for cross-over trials) and other (not included in the
previous categories) bias. Moreover, according to the new author
guidelines from Cochrane Pain, Palliative and Supportive Care
and the recommendations by Moore et al. (2010), followed by the
most recent Cochrane reviews, we included also analysis about
two more potential bias sources: “sample size” and “follow-up
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duration.” The degree of bias risk for such criteria is evaluated
according to the thresholds proposed by Moore et al. (2010). As
concerns “sample size,” studies with less of 50 participants× arm
were considered at high-risk, those between 50–199 at unclear-
risk while a low-risk of bias can be presumed for sizes of 200 or
more. For the criterium of duration, follow-up less than 2 weeks
are considered a high risk, an unclear risk is attributed for
periods ranging from 2–7 weeks, while at low risk for bias are
considered studies with 8 or more weeks evaluation after the end
of stimulation.
On such a basis, different degree of risk bias (high, unclear,
or low) has been attributed for all bias sources to each of
the included studies (see Figure 3). Scoring was performed
independently by authors DTM and BF and disagreement was
solved through consultation with another author (CM).
APPLICATION OF tES FOR TREATMENT
OF FIBROMYALGIA
Fourteen tES studies meeting the selection criteria have been
included. The majority of them (12) employed the tDCS
technique, (Fregni et al., 2006; Roizenblatt et al., 2007; Valle
et al., 2009; Mendonca et al., 2011, 2016; Riberto et al., 2011;
Fagerlund et al., 2015; Jales et al., 2015; Khedr et al., 2017; Silva
et al., 2017; To et al., 2017; Yoo et al., 2018), while other variants
like HD-tDCS, and tRNS have been explored more recently
only in 2 randomized controlled studies (Villamar et al., 2013;
Curatolo et al., 2017). Given the poor evidence available and
the potential of these new techniques, we mentioned, within the
tES variants, two more studies that we considered interesting
FIGURE 3 | Scores for risk bias analysis for all items evaluated in each study
examined. “+”: low risk; “?”: unclear risk; “−”: high risk.
for potential developments even if they don’t meet the criteria
for inclusion, one because open label (Castillo-Saavedra et al.,
2016) or the other one because exploring only feasibility issues
(Carvalho et al., 2018).
Stimulation Parameters
Two brain area were principally targeted in these studies: M1 and
DLPFC that were stimulated alone or compared each-other in the
same trial., M1 alone was stimulated in the majority of reports
(Mendonca et al., 2011, 2016; Riberto et al., 2011; Villamar et al.,
2013; Fagerlund et al., 2015; Jales et al., 2015; Curatolo et al.,
2017; Khedr et al., 2017). DLPFC was targeted in the studies by
Silva et al. (2017); To et al. (2017), and Yoo et al. (2018). DLPFC
and M1 were compared in the studies by Fregni et al. (2006),
Roizenblatt et al. (2007), and Valle et al. (2009). A different brain
area was targeted in the study by Mendonca et al. (2016), that
stimulated supraorbital regions of both sides compared with M1,
using an extracephalic reference and exploring only outcome on
pain and life quality.
Stimulation intensities of 1.5 mA was employed in the studies
by To et al. (2017) and Yoo et al. (2018). Silva et al. (2017),
Curatolo et al. (2017), and Khedr et al. (2017) used 1 mA,
while 2 mA stimulation was performed in the others (most
studies). Stimulation lasted for 20 min in all but one study
(Curatolo et al., 2017) where 15 min. tRNS was delivered.
Treatment schedule changed significantly across studies. Five
daily stimulation sessions were employed by Fregni et al. (2006),
Roizenblatt et al. (2007), Fagerlund et al. (2015), and Mendonca
et al. (2016). The stimulation period was increased to 10 daily
sessions (week-end free) in the reports by Valle et al. (2009);
Curatolo et al. (2017) and Khedr et al. (2017). Longer stimulation
schedules were used by Riberto et al. (2011) and Jales et al.
(2015) (1 week session for 10 weeks) and by To et al. (2017)
and Yoo et al. (2018) that delivered 2 session per week for
4 weeks. Single session stimulation was instead performed in the
studies by Mendonca et al. (2011), Villamar et al. (2013), and
Silva et al. (2017).
All but three studies used cephalic montages with anode on left
side (M1 or DLPFC) and cathode on contralateral supraorbital
area. Bilateral DLPFC stimulation was performed in two studies
with anode on left- in the report by To et al. (2017) or on
the right-side in that by Yoo et al. (2018). An extracephalic
montage was instead used in the study by Mendonca et al.
(2011) comparing M1 vs. supraorbital areas with both anodal and
cathodal polarity (see below).
Outcomes
Pain and impact on life quality, were the most explored outcomes,
while less studies examined also effects on other clinical aspects
like affective and cognitive symptoms, sleep disturbances and
fatigue. In two studies tDCS was explored in add-on with
physical exercise with interesting synergic effects (Riberto et al.,
2011; Mendonca et al., 2016), while in one (Yoo et al., 2018)
authors investigated add-on effects of DLPFC and occipital nerve
stimulation (ONS).
Here we separately describe: (1) tDCS studies, further
distinguishing by outcomes: effects on pain and on other
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symptoms (cognitive and affective disturbances, sleep changes,
fatigue) and by stimulation sites; (2) tDCS studies in add-on with
physical exercise and ONS; and (3) studies on other tES variants
like HD-tDCS, tRNS and home based tDCS treatment.
All studies mentioned employing tES for FMS treatment are
summarized in Tables 1, 2.
tDCS STUDIES: EFFECTS ON PAIN AND
LIFE QUALITY
M1 Stimulation
Fregni et al. (2006), first showed that five sessions of anodal
tDCS over left M1 were able to ameliorate pain and life quality
in patients affected by FMS, as compared to left DLPFC or
sham stimulation (three study groups). The effect was relevant
and significant with respect to placebo (58% vs. 30%) and
persisted lasting for 3 weeks after the stimulation period. DLPFC
stimulation was not effective on pain. but showed a greater (even
if not significant) and more persistent effect on depression at
Beck depression inventory (BDI) scores. Shortly after, positive
effects of M1 stimulation on pain were confirmed by Roizenblatt
et al. (2007) by means of the same experimental design. Further
studies targeting M1 generally confirmed positive effects on
pain and life quality. Using the same experimental design
with 5 days session schedule, Fagerlund et al. (2015) reported
efficacy of anodal M1 tDCS in FMS patients on measure of
pain scores.
Positive effects on pain and life quality were obtained also
in other studies that explored longer stimulation periods to
induce more lasting effects. Valle et al. (2009) increased the
stimulation period from 1 to 2 weeks exploring stimulation
of both M1 and DLPFC areas. They confirmed the efficacy
of the treatment (significant amelioration of pain symptoms
and life quality scores) obtaining also a long-lasting therapeutic
effect that remained up to 2 months after the end of the
stimulation for M1. Khedr et al. (2017), using the same
schedule of 10 days stimulation over left M1, reported significant
and persistent therapeutic effects on pain measures (still
present at the 1 month follow-up) that correlated with an
increase in the levels of serum beta-endorphines. Riberto
et al. (2011) tried a study design with different temporal
distribution (1 session per week for 10 weeks) to extend
the stimulation period and keep the effects of stimulation
longer. They found a significant and relevant effect of anodal
tDCS on life quality but not on pain, that lasted quite
unchanged across all the stimulation period of 10 weeks and
was still present at the 1-week follow-up after stimulation.
Similar and more extensive results were obtained by Jales
et al. (2015), who, using the same temporal design, obtained
amelioration not only of life quality score but also of
pain measures in a group of FMS patients treated with
anodal stimulation as compared to sham stimulation over M1
area. Moreover, using Single photon Emission Tomography
(Brain SPECT) authors showed that tDCS was also able
to ameliorate (reduce) the biparietal hypoperfusion observed
in baseline.
DLPFC Stimulation
Targeting of DLPFC was generally less effective for treatment of
pain in FMS patients. In the three studies comparing M1 and
DLPFC, no effects by DLPFC stimulation was reported by Fregni
et al. (2006) and by Roizenblatt et al. (2007) while a significant but
short lasting (not persistent at follow-up) effect on pain and life
quality was showed by Valle et al. (2009). Differently, significant
changes in pain scores were reported in two more recent studies.
In the single session study by Silva et al. (2017), stimulation of left
DLPFC significantly increased heat pain threshold and tolerance.
In the trial by To et al. (2017) 8 tDCS sessions over bilateral
DLPFC significantly ameliorated pain scores.
Other Stimulation Sites
The great majority of studies performed anodal stimulation of M1
and/or DLPFC areas all with a cephalic reference. Mendonca et al.
(2011) compared stimulation of M1 and supraorbital (SO) region
of left and right side with both anodal and cathodal polarities
and sham (five stimulation conditions) using an extracephalic
reference. They also performed computer simulation to study
currents distribution of the different montages within a head
model based on tridimensional reconstruction of an MRI scan.
Interestingly, they found that SO but not M1 stimulation were
able to ameliorate pain in FMS patients. This, however, was not
surprising because the study of currents distribution within these
specific montages showed flows through the prefrontal areas
(involved in the pain matrix) in SO but not in M1 where currents
distribution instead principally involved the temporal cortex.
tDCS STUDIES: EFFECTS ON OTHER
SYMPTOMS (COGNITIVE AND
AFFECTIVE DISTURBANCES, SLEEP
CHANGES, FATIGUE)
M1 Stimulation
Less studies explored ability of anodal tDCS to ameliorate
cognitive and affective symptoms in FMS patients. In the first
report by Fregni et al. (2006) (comparing effects of DLPFC and
M1 anodal tDCS) authors found that M1 stimulation, able to
ameliorate pain, was instead ineffective on depression. Differently
positive effects on anxiety and mood were reported by Mendonca
et al. (2016) where tDCS over left M1 was coupled with physical
exercise (see below) and in that by Khedr et al. (2017) where M1
stimulation induced significant long-lasting changes at Hamilton
anxiety and depression scales (HAM-A and HAM-D) scores that
was still persistent at 1 month follow-up.
Differently no effects on cognitive/affective symptoms were
reported in the stud by Fagerlund et al. (2015) targeting M1 and in
that by Riberto et al. (2011) that explored the effects of M1 tDCS
in add-on with a rehabilitative protocol (see below).
DLPFC Stimulation
In the study by Fregni et al. (2006), comparing DLPFC and
M1, DLPFC stimulation, that achieved no significant effects on
pain, induced a slight even if not significant changes in the
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TABLE 1 | Transcranial direct currents stimulation (tDCS) studies on fibromyalgia.
Author Study design N. Paz Target Number of sessions Aim Results
Fagerlund
et al., 2015
Randomized,
sham-controlled.
48 patients Left M1 Five sessions of anodal
tDCS 2 mA, 20 min for five
consecutive days.
Relief of pain, stress,
psychiatric symptoms.
Anodal tDCS induced
statistically significant
pain relief. No
significant change for
the other measures.
Fregni et al.,
2006
Randomized,
sham-controlled, proof of
principle.
32 patients Left M1 or
Left DLPFC
Five sessions of anodal
tDCS 2 mA, 20 min for five
consecutive days.
Pain relief. Anodal tDCS of the
primary motor cortex
induced significantly
greater pain relief as
compared to sham; the
effect was still
significant after
3 weeks.
Jales et al.,
2015
Randomized, sham
controlled trial with CT scan
with single photon emission
(Brain-SPECT) evaluation.
20 patients Left M1 10 sessions of anodal tDCS
1 mA, 20 min (once a week
for 10 weeks) and brain
imaging by Brain Perfusion
Scintigraphy.
Pain relief, amelioration
of life quality and
changes in SPECT
imaging.
M1 tDCS was effective
for therapeutic pain
control and improved
quality of life. Significant
changes in imaging
with decreased
biparietal hypoperfusion
after stimulation.
Khedr et al.,
2017
Randomized sham
controlled with evaluation of
serum beta-endorphin
levels (BEL).
40 patients Left M1 10 sessions (5 days/week
for 2 weeks) of anodal
tDCS (1 mA, 20 min).
Dosage of serum BEL.
Follow-up at 15 and
30 days.
Pain, life quality and
mood amelioration and
relation with BEL
changes by WPI, SS,
VAS, pain threshold
(primary outcome);
HAM-D and HAM-A,
serum BEL (secondary
outcomes).
M1 tDCS was effective
on all outcome
measures for pain and
mood; BEL increased
after treatment (both
anodal and sham
groups) showing a
negative correlation
with all other outcomes
in the anodal tDCS
group.
Mendonca
et al., 2011
Randomized sham
controlled.
30 patients Left M1 Left
Supraorbital (SO)
One session; 5 groups:
M1-anodal; M1-cathodal;
SO- anodal; SO-cathodal;
sham (extracephalic
reference electrode).
To determine current
distribution and
short-term analgesic
effects of tDCS using
different electrode
montages. Outcomes:
VNS, PPT, BD.
SO (both cathodal and
anodal) montages,
showing at computer
simulation current flows
through prefrontal
cortex, were effective
on pain. M1 montages
inducing instead
temporal current flows
was ineffective.
Mendonca
et al., 2016
Randomized
sham-controlled tDCS
treatment in add-on to
aerobic exercise.
45 patients Left M1 Five sessions of anodal
tDCS (2 mA, 20 min) for five
consecutive days
combined with aerobic
exercise, 30 min per
session.
Pain relief.; anxiety and
mood amelioration.
The combination
intervention had a
significant effect on
pain, anxiety and
mood.
Riberto et al.,
2011
Randomized sham
controlled coupled with a
physical rehabilitation
program.
23 patients Left M1 Anodal tDCS 2 mA, 20 min.
once a week for 10 weeks,
combined with
multidisciplinary
rehabilitation.
Pain relief and life
quality.
tDCS add-on treatment
showed significantly
greater effects on life
quality with respect to
sham+rehabilitation.
Roizenblatt
et al., 2007
Randomized,
sham-controlled Bilateral.
32 patients Left M1 or left
DLPFC
Five sessions of anodal
tDCS 2 mA, 20 min for five
consecutive days.
Pain relief and sleep
amelioration.
Anodal tDCS was
effective on sleep and
pain. M1 treatment
increased sleep
efficiency and
decreased arousals.
DLPFC decreased
sleep efficiency and
increase rapid eye
movement (REM).
(Continued)
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TABLE 1 | Continued
Author Study design N. Paz Target Number of sessions Aim Results
Silva et al.,
2017
Randomized
sham-controlled.
40 patients Left DLPFC A single session of tDCS
1 mA, 20 min.
Improve alertness,
orienting, executive
control and pain relief.
Anodal tDCS increased
heat pain threshold and
tolerance and
ameliorated orienting
and executive attention.
There was no effect on
alertness.
To et al., 2017 Randomized sham
controlled trial.
42 patients Bilateral DLPFC
Bilateral Occipital
Nerve (ON) area
Three tDCS groups:
DLPFC, ON, sham. Eight
sessions
(2 weeks × 4 weeks) of
anodal stim. (2 min,
1,5 mA).
Pain and fatigue
amelioration.
DLPFC improved pain
and fatigue, while ON
was effective only on
pain.
Valle et al.,
2009
Randomized,
sham-controlled clinical
trial.
41 patients Left M1 Left DLPFC Ten daily sessions
(Monday–Friday, 2 weeks)
of anodal tDCS (20 min,
2 mA).
Pain relief; long lasting
effects by longer
(2 weeks) treatment.
First evidence that 10
daily sessions give
more lasting outcomes.
This long-term effect
was observed only for
M1 stimulation.
Yoo et al., 2018 Randomized sham
controlled clinical trial.
58 patients Bilateral ON
Bilateral DLPFC
Three tDCS groups: ON,
DLPFC+ON, sham; 8
sessions
(2/week × 4 weeks) of
anodal stim. (20 min,
1,5 mA).
To explore the add-on
effect of DLPFC
preceding ON with
respect to ON alone
stimulation on: disability
(FIQ) pain (NRS) and
mood (BDI).
ON stimulation was
effective on all
outcomes measures;
DLPFC prestimulation
added no further
significant effect.
BD, body diagram; BDI, Beck depression inventory; BEL, beta-endorphins levels; CT, computerized tomography; DLPFC, dorsolateral prefrontal cortex; M1, motor
cortex; HAM-D and HAM-A, Hamilton depression and Hamilton anxiety scales; HD-tDCS, high-density tDCS; HS, healthy subjects; NRS, numeric rating scale; ON,
occipital nerve; PPT, pressure pain threshold; SO, supraorbital; SPECT, single photon emission computerized tomography; SS, symptoms severity scale; VAS, visual
analogic scale; tDCS, transcranial direct current stimulation; tRNS, transcranial random noise stimulation; VNS, visual numeric scale; WPI, widespread pain index.
BDI scores. The following year the same group (Roizenblatt
et al., 2007), through the same study design, more specifically
investigated the effect on sleep disturbances, that are frequent
and highly disabling in patients with FMS (Doherty and
Smith, 1993), and its correlation with pain improvement. They
explored clinical and electroencephalographic (EEG) outcomes
and found that anodal M1 stimulation was able to ameliorate
sleep in FMS together with a parallel improvement in pain
experience. M1 tDCS increased the total sleep time and efficiency,
reducing the latency for sleep and REM phase beginning,
increasing also the percentage of slow-wave (delta) epochs at
EEG that are associated with more effective and restorative
sleeping. Differently, opposite effects were achieved by DLPFC
stimulation that reduced sleep time and efficiency, increasing
latencies for the beginning of sleep and REM phase together
with decreasing of delta activity. Such results agree with
previous evidences on effects of anodal tDCS over DLPFC
in patients with mood disorders, where the positive effect on
depression was associated to the increase of arousals and alfa
activity at EEG.
More specific cognitive targets were assessed in a very
recent study (Silva et al., 2017) that explored the cognitive
effects of DLPFC stimulation in FMS focusing more in
detail on selective aspects of attention (alerting, orienting,
and executive). Interestingly they found that a single
session of anodal stimulation had no effect on alertness
but was able to improve both pain and orienting and
executive attention in FMS patients. Moreover, the effect
on attention was found to be independent from that observed
on pain.
Effects on fatigue were explored only in one study
employing tDCS of bilateral DLPFC (with anode on left
side) compared to peripheral occipital nerve stimulation
(ONS). Authors showed that targeting of bilateral DLFPC was
able to significantly ameliorate fatigue together with pain as
compared to ONS that was instead only able to reduce pain
(To et al., 2017).
No changes at all by DLPFC stimulation on measures of
depression and anxiety were instead found in the study by Valle
et al. (2009) comparing DLPFC and M1 stimulation.
EFFECTS OF tES AS SYNERGIC
TREATMENT IN FIBROMYALGIA
Add-On With Physical Exercise
Another therapeutic strategy explored the potential synergic
effects of tDCS in add-on to other therapeutic tools. In the study
by Riberto et al. (2011) the adding of anodal M1 stimulation to
a physical rehabilitative protocol favored a greater effect on pain
control. In a recent paper Mendonca et al. (2016) showed that
anodal M1 stimulation was able to induce a significantly more
consistent effect on pain and life quality if delivered while patient
was performing an aerobic physical exercise.
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TABLE 2 | Other tES studies on fibromyalgia.
Author Study design N. Paz Target Number of sessions Aim Results
Carvalho
et al., 2018
Randomized,
sham-controlled trial.,
with a specific device
for home-based tDCS
treatment.
20 healthy subjects
(HS). 8 patients
Left M1 in HS; Left
DLFC in FMS
patients.
Anodal tDCS (20 min,
2 mA) sessions, 10
continuous daily
sessions in HS; 5 days
(Monday–Friday) for
12 weeks (60 sessions)
in FMS patients. tDCS
machines specifically
suited for home-based
stimulation.
Feasibility of
home-based tDCS
treatment for FMS.
In both groups optimal
adherence to the protocol
(>90%), good impedance
control and general
tolerability and safety of the
device.
Castillo-
Saavedra
et al., 2016
Phase II open-label
HD-tDCS study.
20 patients Left M1 At least 15 daily
sessions of HD-tDCS.
To establish the number
of HD-tDCS sessions
required to achieve a
50% pain reduction.
HD-tDCS application
maintained for 6 weeks
showing a significant and
relevant cumulative
therapeutic effect. The trial
estimate 15 as the median
number of HD-tDCS
sessions to reach clinically
meaningful outcomes.
Curatolo
et al., 2017
Randomized,
sham-controlled tRNS
study.
20 patients Left M1 10 daily sessions
(Monday–Friday,
2 weeks) of tRNS
(15 min. 1 mA,
100–600 Hz).
To evaluate effects on
pain, cognitive and
mood disturbance.
This study is the first
evidence about the effect of
left motor cortex tRNS on
pain, cognitive and mood
disturbances in
fibromyalgia.
Villamar
et al., 2013
Randomized,
sham-controlled,
crossover HD-tDCS
study.
18 patients Left M1 Single session of
anodal, cathodal, and
sham HD-tDCS 2.0
mA, 20 min.
Pain relief. M1 cathodal HD-tDCS
stimulation led to significant
reduction in overall
perceived pain. 30 min after
stimulation pain relief was
still present cathodal and
emerged also for anodal
polarity (tardive effect).
BD, body diagram; BDI, Beck depression inventory; BEL, beta-endorphins levels; CT, computerized tomography; DLPFC, dorsolateral prefrontal cortex; M1, motor
cortex; HAM-D and HAM-A, Hamilton depression and Hamilton anxiety scales; HD-tDCS, high-density tDCS; HS, healthy subjects; NRS, numeric rating scale; ON,
occipital nerve; PPT, pressure pain threshold; SO, supraorbital; SPECT, single photon emission computerized tomography; SS, symptoms severity scale; VAS, visual
analogic scale; tDCS, transcranial direct current stimulation; tRNS, transcranial random noise stimulation; VNS, visual numeric scale; WPI, widespread pain index.
It is known that aerobic exercise can affect a large
neural circuit inducing neuroendocrine responses
(Schwarz and Kindermann, 1992; Goldfarb and Jamurtas,
1997; Kramer and Erickson, 2007) and other long-lasting
mechanism favoring the maintenance of the improvement
(Colcombe et al., 2004; Mang et al., 2016; Lulic et al., 2017).
Exercise, in fact, modulates the activity in specific cortical
regions by learning tools, leading to long-term potentiation
mechanisms (Erickson and Kramer, 2009). Mendonca et al.
(2016) proved that neuromodulation with tDCS in association
with an aerobic exercise training determined a relevant effect
on pain, anxiety and mood, probably through a sequential
activation and modification of the system by tDCS and exercise,
respectively. The same combination approach might have
influenced other neural circuits, such as those governing the
affective-emotional aspects of pain. Indeed, areas involved
in processing of emotions and affective states and more in
particular the fronto-limbic network showed impairment
in FMS and this could account for abnormal response to
pain and for affective disturbance that are both parts of the
clinical picture of the disease. This appears worth to mention
because the same areas and networks can be modulated by
exercise and physical activity that, in turn, has been showed
able to ameliorate pain states as well anxiety and depression
symptoms (Sciolino and Holmes, 2012; Archer et al., 2014;
Kregel et al., 2017).
Other Add-On Treatments
Another add-on strategy was explored by Yoo et al. (2018)
that investigated association of DLPFC stimulation together with
ONS and found no further significant advantage of add-on with
respect to ONS alone that was effective on measure of pain, life
quality and mood.
EFFECTS OF NEW tES VARIANTS IN
FIBROMYALGIA
Besides classical direct current approach, the most till now
employed, new application of tES have been recently tried for
treatment of FMS. Two recent studies explored the effects of
HD-tDCS. Villamar et al. (2013) performed single sessions of
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HD-tDCS centered over motor cortex (anodal., cathodal, and
sham) in FMS patients, showing that both anodal and cathodal
polarities were able to induce significant amelioration of pain.
The effect started first with cathodal currents and lasted till
30 min after the end of stimulation for both polarities. In
another recent open label study with a dose-finding approach,
Castillo-Saavedra et al. (2016), explored the effect of long-
term HD-tDCS application maintained for 6 weeks, showing
a significant and relevant cumulative therapeutic effect (>50%
pain reduction and significant amelioration in life quality scores)
in one half of the treated patients that persisted across all the
stimulation period.
Despite the great interest raised about alternate currents
and their potential to interact with the ongoing cortical
rhythms and function, no study has until now investigated
the therapeutic ability of tACS in fibromyalgia. Our group
recently explored the approach of tRNS over motor cortex
to treat pain and associated symptoms (cognitive and mood
dysfunctions) in patients with FMS. We chose this new approach
because the motor cortex was a successful target for the
majority of anodal tDCS trials in FMS patients and also
because tRNS over motor cortex induced greater facilitation
of evoked motor potentials with respect to anodal tDCS
(Moliadze et al., 2014; Inukai et al., 2016) showing efficacy not
only on pain but also on accompanying mood and cognitive
impairment in patients with different pain syndromes (Alm
and Dreimanis, 2013; Palm et al., 2016). We treated 2 group
of ten patients with real and with sham tRNS, respectively.
We evaluated pain, mood and cognitive dysfunctions with a
particular focus on the so called fibrofog syndrome that was
examined exploring both subjective complains and objective
measures of cognitive impairment that characterize fibrofog
manifestation, i.e., executive, attentive and working memory
performances. After 2 weeks of treatment we observed an
extensive therapeutic effect with consistent amelioration of pain
and life quality, mood and cognitive measures of fibrofog
(Curatolo et al., 2017).
In all these studies, however, patients had to reach Hospitals
or Clinical or Research Centers to underwent tES treatment.
Differently, in a very recent study on FMS patients, Carvalho et al.
(2018) explored the feasibility for home-based tDCS treatment
through specifically designed machines equipped with a security
control system to guarantee safe application and a software
for monitoring stimulation. A group of healthy subjects and
one of FMS patients were recruited and trained to use the
stimulator. All performed self-stimulation at home through a
neoprene cap (easily positioned on the scalp) where preinstalled
electrodes were inserted to achieve stimulation of the target area:
left DLPFC in FMS patients and left M1 in healthy subjects
(HS). Anodal stimulation was delivered (2 mA for 2 min)
daily for 5 days a week for a total of 12 weeks (60 sessions)
in FMS and continuously for 10 days in HS. In both groups
adherence to the study was optimal (more than 90%), electrode
impedance (a critical variable to avoid skin lesions) maintained
low and very few side effects were reported (not different in
type, intensity and severity from those observed in the other
tDCS studies).
SAFETY AND RISK BIAS ANALYSIS
Safety
Transcranial direct currents stimulation was safe and well
tolerated in all the studies examined and no serious side effects
were reported. The most frequent complaints concerned only
itching and tingling sensations that were, however, short-living,
vanishing completely in a few minutes after stimulation.
Randomization and Blinding
All included studies were randomized but randomization criteria
were adequately described in 8/14 (57%), leaving a condition
of unclear risk bias in the remaining. More concerns are for
blinding because strategy for ensure accurate blinding of subjects
and assessor are described only in 3/14 (21.5%) and 4/14 (28.6%)
respectively, of the studies examined configuring a condition
of unclear risk-bias in the remaining. As concerns blinding of
subject a critical factor is represented for stimulation intensity,
as for currents ≥ 1.5 mA the subject could be able to distinguish
between sham and real stimulation. At these intensities indeed,
cutaneous sensations could persist across the stimulation period.
Incomplete Outcome Data and Selective
Reporting
The bias risk for incomplete outcome data was generally low
as the majority of studies (10/14: 71.4%) correctly addressed
this issue reporting opportunely about drop-out level. Similarly,
a low bias risk has been found in 8/14 (57%) studies as
concerns selective reporting. However, 3 studies (Valle et al.,
2009; Mendonca et al., 2011; Curatolo et al., 2017) have been
considered at high bias risk because data for size effect calculation
at the time points of the study have not been made available by
the authors.
Sample-Size and Follow-Up Duration
All studies examined were based on small samples (less than 20
subjects per arm) configuring therefore a condition of high-risk
bias according to the criteria by Moore et al. (2010). Also not
appropriate in 6/14 studies (42.8%) was the duration of follow-
up because less than 2 weeks or because no evaluation at all was
performed to assess the persistence of therapeutic effects.
Generally, the studies performing prolonged stimulation
obtained longer lasting therapeutic effect. Ten instead than
five stimulation days was able to maintain benefit on pain at
one (Khedr et al., 2017) and 2 months follow-up (Valle et al.,
2009). Moreover, the strategy to prolong the stimulation period
reducing the frequency of the session to one per week was able
to maintain the therapeutic effects for 10 weeks in the studies by
Riberto et al. (2011) and Jales et al. (2015).
DISCUSSION
Summary of the Results
To summarize, the analysis of the tES studies on treatment of
FMS evaluated in the review, showed that anodal tDCS of motor
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cortex, that represent the most studied stimulation target, is
able to induce significant therapeutic effects on pain measures
and/or life quality in FMS patients, as compared to placebo sham
tDCS. Less evidence instead is available about efficacy on other
symptoms of FMS (cognitive, affective and sleep disturbances and
fatigue) also because these and in particular cognitive dysfunction
and fatigue have been generally less explored in the tES studies
examined and specially in those targeting M1. Indeed, a few M1
studies reported efficacy on affective symptoms and only one,
based on a new tES approach (tRNS) showed therapeutic effects
on both motor and cognitive/affective manifestations of FMS
(Curatolo et al., 2017).
The other target area studied, DLPFC, was explored only
in a few reports and was less effective. A limited, short
lasting efficacy on pain and life quality was showed only
in other studies (Valle et al., 2009; To et al., 2017) where
stimulation time longer than 5 days were used. Differently,
positive outcome on attention components was found in the
study by Silva et al. (2017). This is partly at variance with
studies by rTMS where stimulation of DLPFC showed less
effect on pain as compared with M1 site but a greater,
more consistent response on mood and cognitive disturbances.
The reason for such discrepancies and more in general the
pathophysiological mechanisms underlying the effects of tES
in the studies examined remain to be delineated. However,
concerning the comparison between rTMS and tES about DLPFC
effects, a critical general factor could be simply be represented
by the very few tES studies exploring the effect of DLPFC
and more in particular the outcome on cognitive functions
and fatigue. On the other hand, it could not be excluded a
greater effect of rTMS on DLPFC at least as concerns affective
disorders of FMS, (the ones principally explored) even if
this appears less likely due to the proved efficacy of DLPFC
tDCS in treatment of resistant and non-resistant depression
(Mutz et al., 2018).
Concerning mechanisms underlying the effects of M1 or
DLPFC stimulation we have only sparse, direct evidence
(trough imaging studies), about activity or connectivity changes
induced by the modulation of the target areas and their
correlation with the clinical outcome. The study by Jales
et al. (2015) found, through brain SPECT imaging, that
tDCS treatment on M1 was able to normalize the bilateral
parietal hypoperfusion observed at baseline in FMS patient.
Cummiford et al. (2016) (report not included in the review
because not randomized) studied changes in fMRI resting state
and showed, after M1 stimulation, a quite specific pattern of
reduced connectivity between thalamus primary motor and
sensory areas that correlates with the clinical outcome of
pain reduction. This appears in line with the mechanism of
anti-dromic inhibitory thalamic modulation that represent one
of the ways suggested to explain the analgesic effect of M1
stimulation in different pain states. Differently from M1, no
study specifically explored mechanisms underlying the effects of
DLPFC stimulation in FMS patients. However, even considering
the poor therapeutic evidence available about this target in
FMS, one can reasonably infers that the effects of DLPFC
stimulation would follow to the known network connectivity of
this region. So, the ability of DLPFC to exert antinociceptive
effects trough the link with the DNIC system could explain
effect on pain, while amelioration of cognitive and affective
disturbances can be induced through the connections with the
limbic system.
LIMITATIONS AND FUTURE DIRECTIONS
Even if M1 stimulation showed significant ability to ameliorate
pain and life quality in FMS in the studies examined, several
critical aspects emerge, principally by the risk bias analysis,
that reduce the strength of the observed effect. The quality
of evidence is indeed hampered by the small patient series
investigated, the lack of effective and accurate blinding and
the consistent methodological heterogeneity across studies.
Moreover, a substantial lack of knowledge remains about
the ability to maintain the therapeutic effects over time as
only a limited evidence is at moment available about long
lasting stimulation protocols. Given to this criticism, anodal
M1 tDCS didn’t reach an evidence level to be considered a
certainly effective procedure for treatment of FMS. A level
B recommendation (probably effective) was indeed provided
by a recent consensus paper by the European chapter of the
International Society of Clinical Neurophysiology (Lefaucheur
et al., 2017) while an even more cautious advice was expressed
by a specially suited commission of the European Academy
of Neurology. This indeed, based on the method of GRADE
(Grading of Recommendations, Assessment, Development, and
Evaluation) judged anodal tDCS of motor cortex as still
inconclusive for treatment of FMS (Cruccu et al., 2016). A similar
critical position was expressed also by the most recent Cochrane
review about non-invasive neurostimulation for chronic pain
(O’Connell et al., 2018) that, even including more reports with
respect of previous evaluation (O’Connell et al., 2014), considered
evidence about tES still poor and inconclusive.
Even considering this criticism, tES approach thanks to its
safety, ease of use and potential for home-based treatment
is worth to be further explored to better define its real
therapeutic potential.
Therefore, operational strategies are needed to overcome
limitations emerged in the available reports and to exploit the
potential of new tES based approaches. To this aim it appears of
striking importance to:
(1) Plan adequately powered, randomized controlled trials
(20 or more patients × arm) taking care of accurate
randomization and blinding and more homogenous
methodology, with stimulation periods and follow-up of at
least 2 weeks.
(2) Explore, trough appropriately designed RCT studies the
ability to maintain long term therapeutic effects through
maintenance protocols.
(3) Investigate the potential of new tES stimulation methods
like HD-tDCS, tRNS, and tACS, and the add-on
combination with other non-stimulation approaches
and, last but not least, the generation of new devices for
home-based treatment.
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All these lines of action are worth to be followed, better
through a consensus between researchers, (to ensure opportunely
powered and methodologically homogeneous trials) to make the
final point about the efficacy of tDCS and other tES variants
for treatment of fibromyalgia. This, with final aim to obtain
the most effective, extensive, and lasting therapeutic effects
through the most easy and inexpensive approach for treatment
of FMS patients.
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